Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, with sites in Belgium, United States, Japan and India, providing comprehensive process development services, cGMP manufacturing and drug product fill finish services of small molecule and biologic APIs and intermediates. We offer a broad range of innovative platforms and capabilities to rapidly scale from clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our clients’ needs.

Ajinomoto Bio-Pharma Services offers a range capabilities through its facilities around the world. Our facilities in Belgium, Japan, and India focus on conventional small molecule API and intermediate production.  The focus at our California, USA facility is on large molecule and ADC manufacturing and aseptic fill finish services. Our Osaka, Japan facilities focus on oligonucleotide synthesis.

Our expertise and extensive knowledge of international requirements help assure your product will meet the highest possible quality standards. Our goal is to deliver quality product and personalized service, while providing flexibility and guidance to help our clients achieve their goals in a timely and efficient, cost-effective manner.

Ajinomoto Bio-Pharma Services is a member of the Ajinomoto Group companies, a global company focused on the research, development, and manufacture of high quality products for the pharmaceutical, specialty chemical, nutraceutical, sports nutrition, and health & beauty industries, as well as food seasonings and consumer food products.